Isolation of CD34+ hematopoietic progenitor cells in chronic myeloid leukemia by magnetic activated cell sorting (MACS)

Bone Marrow Transplantation

Volumn 18, Issue 3, 1996, Pages 603-609

  Martin Henao G A ^a   Ingles Esteve J ^a   Cancelas, J A ^a   Garcia J ^a  

^a HOSPITAL DURAN I REYNALS   (Spain)

Author keywords

CD34+ cells; Chronic myeloid leukemia; Positive selection

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; HLA DR ANTIGEN; RECEPTOR; STEM CELL FACTOR;

ADULT; APHERESIS; ARTICLE; BLOOD; BONE MARROW; CELL ISOLATION; CELL SELECTION; CELL SEPARATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MAGNETIC FIELD; MALE; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD34; FEMALE; HEMATOPOIETIC STEM CELLS; HLA-DR ANTIGENS; HUMANS; IMMUNOMAGNETIC SEPARATION; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED;

EID: 0029792475     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Miltenyi S, Müller W, Weichel W, Radbruch A. High gradient magnetic cell separation with MACS. Cytometry 1990; 11: 231-238.
2. Civin CI, Strauss LC, Brovall C et al. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1987; 133: 157-165.
3. Berenson RJ, Andrews RG, Bensinger WI et al. Stem cell selection: clinical experience. In: Gross S, Gee A, Worthington-White DA (eds). Bone Marrow Purging and Processing. Wiley-Liss: New York, 1990, pp 403-413.
4. + cells: a short review of the immunoadsorption methods currently available for experimental and clinical use. J Hematother 1993; 2: 473-481.
5. Kogler G, Capdeville AB, Hauch M et al. High efficiency of a new immunological magnetic cell sorting method for T cell depletion of human bone marrow. Bone Marrow Transplant 1990; 6: 163-168.
6. Civin CI, Loken MR. Cell surface antigens on human marrow cells: dissection of hematopoietic development using monoclonal antibodies and multiparameter flow cytometry. Int J Cell Cloning 1987; 5: 267-288.
7. Winslow JM, Liesveld JL, Ryan DH et al. CD34+ progenitor cell isolation from blood and marrow: a comparison of techniques for small-scale selection. Bone Marrow Transplant 1994, 14: 265-271.
8. Fialkow P, Jacobson R, Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 1977; 63: 125-131.
9. Dunbar CE, Stewart FM. Separating the wheat from the chaff: selection of benign hematopoietic cells in chronic myeloid leukemia. Blood 1992; 79: 1107-1110.
10. Verfaillie CM, Miller WJ, Boylan K, McGlave PB. Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood 1992; 79: 1003-1010.
11. Kirk JA, Reems JA, Roecklein BA et al. Benign marrow progenitors are enriched in the CD34+/HLA-DRlo population but not in the CD34+/CD38lo population in chronic myeloid leukemia: an analysis using interphase fluorescence in situ hybridization. Blood 1995; 86: 737-743.
12. Rusten LS, Jacobsen SEW, Kaalhus O et al. Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells. Blood 1994; 84: 1473-1481.
13. Simmons PJ, Aylett GW, Niutta S et al. c-KIT is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture. Exp Hematol 1994; 22: 157-165.
14. Kreissig C, Kirsch A, Serke S. Characterization and measurement of CD34-expressing hematopoietic cells. J Hematother 1994; 3: 263-289.
15. Coutinho LH, Gilleece MH, De Wynter EA et al. Clonal and long-term cultures using human bone marrow. In: Testa NG, Molineux G (eds). Haemopoiesis, a Practical Approach. Oxford University Press: Oxford, 1993, p 75.
16. Gore SD, Amin S, Weng LJ, Civin CI. Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors. Exp Hematol 1995; 23: 413-421.